Waltham, MA, United States of America

Kaiming Sun


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kaiming Sun: Innovator in Cancer Treatment

Introduction

Kaiming Sun is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 2 patents, his work focuses on combination therapies that enhance the effectiveness of cancer treatments.

Latest Patents

Kaiming Sun's latest patents include groundbreaking methods for treating cancer. One patent details combination therapies for treating cancer with niraparib and PD-1 inhibitors. This invention provides methods of treatment that utilize an agent inhibiting programmed death-1 protein (PD-1) signaling alongside an agent that inhibits poly[ADP-ribose] polymerase (PARP) signaling. Another patent focuses on combination therapies for treating cancer through methods that involve an agent regulating activity within the tumor microenvironment in conjunction with an agent that inhibits PARP signaling.

Career Highlights

Kaiming Sun is currently associated with Tesaro, Inc., a company known for its commitment to developing innovative cancer therapies. His work at Tesaro has positioned him as a key player in the advancement of cancer treatment methodologies.

Collaborations

Kaiming Sun has collaborated with notable colleagues, including Jing Yu Wang and Zebin Wang. These partnerships have contributed to the development of effective cancer treatment strategies.

Conclusion

Kaiming Sun's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work continues to influence the field of oncology and offers hope for more effective cancer therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…